Article
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Annals of internal medicine - 4 Jul 2000
Gulick R M, Mellors J W, Havlir D, Eron J J, Meibohm A, Condra J H, Valentine F T, McMahon D, Gonzalez C, Jonas L, Emini E A, Chodakewitz J A, Isaacs R, Richman D D
Abstract excerpt
BACKGROUND: Antiretroviral regimens containing HIV protease inhibitors suppress viremia in HIV-infected patients, but the durability of this effect is not known. OBJECTIVE: To describe the 3-year follow-up of patients randomly assigned to receive indinavir, zidovudine, and lamivudine in an ongoing clinical trial. DESIGN: Open-label extension of a randomized, double-blind study. SETTING: Four clinical research...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.